This was further corroborated by Western blots that demonstrated a significant time- and dose-dependent upregulation of autophagy markers Lamp1 and LC3B in ASR490-treated BCSCs and BC cells (Figures 5E–J). Here, LAMP1 is linked to breast cancer.